The Veteran's disability rating for residuals of prostate cancer, status post brachytherapy, was reduced from 100% to 60%. The Board found that the reduction was proper and that a higher rating is not warranted at any point in time.
The deciding factor: The Veteran already has the maximum schedular rating assignable under the rating schedule for urine leakage, frequency, and obstructed voiding. There is no indication of renal dysfunction with persistent edema and albuminuria or creatinine levels above 8mg%.
- Claimed conditions
- Prostate cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- April 2, 2015
- Citation
- 1514250
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1514250.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's arteriosclerotic heart disease is rated at 100% effective October 25, 2024. His prostate cancer residuals are rated at 60% effective October 25, 2024.
- Granted
The Veteran's acquired psychiatric disorder and prostate cancer are granted service connection, with the latter requiring a VA examination to address exposure to burn pits.
- Denied
The Veteran's claim for service connection for hearing loss in the right ear has been denied. The Board found that there is no current diagnosis of right ear hearing loss and thus, cannot establish a link to service. For prostate cancer, the Veteran's claim is remanded as VA did not provide an opinion regarding whether his condition may be related to service due to toxic exposure.
- Denied
The Veteran's prostate cancer residuals prior to January 5, 2026 are rated at 10 percent. From January 5, 2026, the Veteran is granted a 20 percent rating for his prostate cancer residuals. The Veteran's left ear hearing loss is not compensable.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.